All terms in GO
| Label | Id | Description |
|---|---|---|
| cardiac muscle cell fate commitment | GO_0060923 | [The commitment of cells to specific cardiac muscle cell fates and their capacity to differentiate into cardiac muscle cells. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.] |
| ventricular cardiac muscle cell fate commitment | GO_0060925 | [The commitment of cells to ventricular cardiac muscle cell fates and their capacity to differentiate into cardiac muscle cells of the ventricle. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.] |
| atrioventricular node cell differentiation | GO_0060922 | [The process in which a relatively unspecialized cell acquires specialized features of an atrioventricular (AV) node cell. AV node cells are pacemaker cells that are found in the atrioventricular node.] |
| cardiac septum cell differentiation | GO_0003292 | [The process in which an endocardial cushion cell becomes a cell of a cardiac septum.] |
| atrioventricular node development | GO_0003162 | [The process whose specific outcome is the progression of the atrioventricular (AV) node over time, from its formation to the mature structure. The AV node is part of the cardiac conduction system that controls the timing of ventricle contraction by receiving electrical signals from the sinoatrial (SA) node and relaying them to the His-Purkinje system.] |
| cardiac cell fate commitment | GO_0060911 | [The commitment of cells to specific cardiac cell fates and their capacity to differentiate into cardiac cells. Cardiac cells are cells that comprise the organ which pumps blood through the circulatory system.] |
| atrioventricular node cell development | GO_0060928 | [The process whose specific outcome is the progression of an atrioventricular (AV) node cell over time, from its formation to the mature state.] |
| cardiac pacemaker cell development | GO_0060926 | [The process whose specific outcome is the progression of a pacemaker cell over time, from its formation to the mature state. Pacemaker cells are specialized cardiomyocytes that are responsible for regulating the timing of heart contractions.] |
| atrioventricular node cell fate commitment | GO_0060929 | [The commitment of cells to atrioventricular (AV) node cell fates and their capacity to differentiate into AV node cells.] |
| cardiac pacemaker cell fate commitment | GO_0060927 | [The commitment of cells to pacemaker cell fates and their capacity to differentiate into pacemaker cells. Pacemaker cells are specialized cardiomyocytes that are responsible for regulating the timing of heart contractions.] |
| regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | GO_0072367 | [Any process that modulates the frequency, rate or extent of lipid transport by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.] |
| positive regulation of sterol import by positive regulation of transcription from RNA polymerase II promoter | GO_0035969 | [Any process that activates or increases the frequency, rate or extent of sterol import by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.] |
| regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | GO_0072369 | [Any process that modulates the frequency, rate or extent of lipid transport by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.] |
| response to topologically incorrect protein | GO_0035966 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure.] |
| regulation of oligopeptide transport by regulation of transcription from RNA polymerase II promoter | GO_0035950 | [Any process that modulates the frequency, rate or extent of oligopeptide transport, by regulation of transcription from an RNA polymerase II promoter.] |
| sinoatrial node cell development | GO_0060931 | [The process whose specific outcome is the progression of a sinoatrial (SA) node cell over time, from its formation to the mature state. SA node cells are pacemaker cells that are found in the sinoatrial node.] |
| regulation of dipeptide transport by regulation of transcription from RNA polymerase II promoter | GO_0035953 | [Any process that modulates the frequency, rate or extent of dipeptide transport, by regulation of transcription from an RNA polymerase II promoter.] |
| His-Purkinje system cell differentiation | GO_0060932 | [The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of a cell of the His-Purkinje system. These cells form the fibers regulate cardiac muscle contraction in the ventricles.] |
| His-Purkinje system development | GO_0003164 | [The process whose specific outcome is the progression of the His-Purkinje system over time, from its formation to the mature structure. The His-Purkinje system receives signals from the AV node and is composed of the fibers that regulate cardiac muscle contraction in the ventricles.] |
| positive regulation of dipeptide transport by positive regulation of transcription from RNA polymerase II promoter | GO_0035954 | [Any process that activates or increases the frequency, rate or extent of dipeptide transport by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.] |